Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia
Clinical trial NCT03564678 · TERMINATED
Trial details
- NCT number
- NCT03564678
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2024-10-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.